Mechanisms of SGLT2 Inhibitors and Diuretics in HF Mechanisms of SGLT2 Inhibitors and Diuretics in HF

A new analysis helps clarify our understanding of how SGLT2 inhibitors reduce the risk of adverse outcome in patients with HFpEF, HFmrEF, and HFrEF.European Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news